IdentifySensors Biologics
OperatingIdentifySensors Biologics Corp.
Healthcare · Shaker Heights, OH
Financials
FY2019–FY2025 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Jun 30, 2025| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Preferred stockpreferred | 3,138,282 | — | 6.25% | — |
| Common Stock | 47,079,716 | — | 93.8% | $4.50Jan 2024 |
| Total | 50,217,998 | 100% |
Shares outstanding over timein today's share terms
Sold to the crowd
- Reg CF · Jan 202421,595 shares at $4.50$97.2K
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
17 peopleShow 8 more peopleShow fewer
Names and titles as disclosed on SEC Form 1-A, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 1 of 3 annual reports (FY2023–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 40 filings on EDGAR- Form 1-SAJul 28, 20260001683168-26-005787EDGAR
- Form 1-KJan 20, 20260001683168-26-000417EDGAR
- Form 1-SAJul 30, 20250001683168-25-005494EDGAR
- Form C/AJun 16, 20250001817371-25-000004EDGAR
- Form C-ARJun 16, 20250001817371-25-000003EDGAR
- Form 1-KMar 27, 20250001683168-25-001918EDGAR
- Form C-UDec 13, 20240001817371-24-000009EDGAR
- Form C/AJul 25, 20240001817371-24-000008EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.